Vertex fires 370 employees, 15% of workforce, as hepatitis C drug sales drop
This article was originally published in Scrip
Executive Summary
Vertex Pharmaceuticals said it is cutting 370 jobs, or 15% of its workforce, as sales of its hepatitis C drug Incivek plummets.